Dr. John Friedewald, MD
Nephrology (Kidney) (Nephrology Physician)
675 N Saint Clair St, Galter 17-200
Chicago, IL 60611
Who else practices at this address →
Cook County includes primary care (3% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Columbia University College of Physicians and Surgeons (1998)
- Years since graduation
- 28
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 252
Licensed in Illinois since 2005, according to the Illinois Department of Financial and Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1998Medical school: Columbia University College of Physicians and Surgeons
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
IL license 036113031 (first issued 2005; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Northwestern Medicine Central Dupage Hospital Winfield, IL
- Northwestern Memorial Hospital Chicago, IL
- Northwestern Lake Forest Hospital Lake Forest, IL
- Palos Community Hospital Palos Heights, IL
Medical groups
- Northwestern Medical Faculty Foundation (4,503 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 252
- Services billed
- 866
- Patients’ average age
- 62
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 159 | 68 |
| Established patient office or other outpatient visit, 30-39 minutes | 88 | 82 |
| Insertion of needle into vein for collection of blood sample | 56 | 17 |
| Established patient office or other outpatient visit, 40-54 minutes | 50 | 47 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 22 | 21 |
| Telephone medical discussion with physician, 21-30 minutes | 22 | 22 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 15 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in Chicago, IL | 447 |
| Prednisone Other prescribers in Chicago, IL | 157 |
| Carvedilol Other prescribers in Chicago, IL | 72 |
| Amlodipine Besylate Other prescribers in Chicago, IL | 59 |
| Tacrolimus Other prescribers in Chicago, IL | 58 |
| Famotidine Other prescribers in Chicago, IL | 55 |
| Nifedipine Er (nifedipine) Other prescribers in Chicago, IL | 35 |
| Losartan Potassium Other prescribers in Chicago, IL | 30 |
| Mycophenolate Mofetil Other prescribers in Chicago, IL | 29 |
| Valganciclovir Hcl | 27 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 13 payments worth $10,931 in total to this clinician.
| Vertex Pharmaceuticals Incorporated | $5,081 |
|---|---|
| Sanofi-aventis U.S. LLC | $3,765 |
| One Lambda, Inc. | $2,049 |
| Alexion Pharmaceuticals, Inc. | $34.95 |
| Consulting Fee | $4,960 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $3,504 |
| Travel and Lodging | $1,441 |
| Food and Beverage | $1,026 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Sanofi-aventis U.S. LLC Oct 8, 2025 | Compensation for services other than consulting (speaking, faculty) THYMOGLOBULIN · Oncology | $3,504 |
| Vertex Pharmaceuticals Incorporated Nov 12, 2025 | Consulting Fee | $2,860 |
| One Lambda, Inc. Mar 13, 2025 | Travel and Lodging travel to Savannah, GA | $1,411 |
| Vertex Pharmaceuticals Incorporated Mar 10, 2025 | Consulting Fee | $900 |
| Vertex Pharmaceuticals Incorporated Mar 7, 2025 | Consulting Fee | $600 |
| Vertex Pharmaceuticals Incorporated Apr 23, 2025 | Consulting Fee | $600 |
| Sanofi-aventis U.S. LLC Oct 8, 2025 | Travel and Lodging THYMOGLOBULIN · Oncology · travel to Oak Brook, IL | $29.40 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $69,542 in research payments for these studies, mostly to the institutions running them.
- An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
Regeneron Pharmaceuticals, Inc. · Recruiting · NCT05106387 - Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients
Csl Behring · Terminated · NCT03744910 - A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)
Regeneron Pharmaceuticals, Inc. · Active, not recruiting · NCT05092347
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.